Procaps Group, S.A Return on Tangible Equity 2020-2023 | PROCF
Current and historical return on tangible equity values for Procaps Group, S.A (PROCF) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Procaps Group, S.A Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2023-09-30 |
$0.05B |
$-0.01B |
-214.43% |
| 2023-06-30 |
$0.07B |
$-0.01B |
-197.06% |
| 2023-03-31 |
$0.03B |
$-0.04B |
-69.11% |
| 2022-12-31 |
$0.04B |
$-0.04B |
-78.14% |
| 2022-09-30 |
$0.06B |
$-0.05B |
-96.00% |
| 2022-06-30 |
$-0.07B |
$-0.07B |
150.25% |
| 2022-03-31 |
$-0.07B |
$-0.06B |
172.15% |
| 2021-12-31 |
$-0.10B |
$-0.08B |
331.15% |
| 2021-09-30 |
$-0.14B |
$0.01B |
160.71% |
| 2021-06-30 |
$-0.03B |
$-0.03B |
29.76% |
| 2021-03-31 |
$-0.03B |
$-0.02B |
37.09% |
| 2020-12-31 |
$-0.01B |
$-0.29B |
13.14% |
| 2020-09-30 |
$-0.01B |
$0.01B |
-100.00% |
| 2019-12-31 |
$-0.00B |
$0.01B |
-160.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
